Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer


KARABULUT M. , ALIS H., Afsar C. U. , Karabulut S., KOCATAS A., Oguz H., ...Daha Fazla

BIOMEDICINE & PHARMACOTHERAPY, cilt.73, ss.140-146, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 73
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.biopha.2015.06.010
  • Dergi Adı: BIOMEDICINE & PHARMACOTHERAPY
  • Sayfa Sayıları: ss.140-146

Özet

Background: Neural precursor cell-expressed, developmentally down regulated 9 (NEDD9), a member of Crk-associated substrate (CAS) family, is highly expressed in multiple cancer types and involved in cancer cell adhesion, migration and invasion. The prognostic value of NEDD9 has been evaluated before and its expression is a predictor of poor prognosis in cancer patients. The objective of this study was to determine the clinical significance of the serum levels of NEDD9 in gastric cancer (GC) patients.